New AI Partnership in Life Sciences Consulting
SSI Strategy LLC has partnered with MPS Metalmind AB to enhance its service offerings through advanced AI capabilities.
SSI Strategy LLC, a leader in strategic consulting for life sciences, has announced a partnership with MPS Metalmind AB, an innovator in AI services. This collaboration marks a significant shift for SSI Strategy, highlighting the need to leveraging cutting-edge artificial intelligence to drive innovation. It also is another significant player in the life sciences space looking to work with AI to enhance their existing capabilities, continuing a clear industry shift.
By integrating Metalmind’s advanced capabilities in natural language processing (NLP) and large language models (LLMs), SSI Strategy aims to significantly improve its service delivery. This strategic partnership will enable SSI Strategy to efficiently identify potential client organisations that can benefit from their market-leading clinical and regulatory expertise. Additionally, it will facilitate the generation of high-quality, specialised content and documentation tailored to the unique needs of their clients.
Johan Strömquist, Chief Innovation Officer at SSI Strategy, expressed his enthusiasm about the partnership, stating, “Partnering with Metalmind opens new possibilities for SSI Strategy, enhancing our service offerings and strengthening our market position. This collaboration positions SSI Strategy as a leader in AI-supported consulting services and allows us to scale to meet growing client demands without compromising quality.”
Headquartered in Parsippany, USA, SSI Strategy is dedicated to supporting the medical office needs of life science organisations. The firm helps clients maximise therapeutic value from translational development to product launch, expertly navigating the complexities of bringing important therapeutics to market. This partnership with Metalmind will aim to further bolster their ability to streamline processes and offer more tailored solutions to clients in the life sciences sector.
Based in Kista, Sweden, Metalmind is a pioneering AI service provider specialising in NLP solutions, knowledge graphs, document generation, and conversational agents. The company is committed to delivering innovative AI technologies that transform business processes and enhance decision-making capabilities. Metalmind’s advanced AI capabilities will streamline interactions with SSI Strategy, making it easier to align on regulatory and clinical requirements. This can lead to faster approval times and more efficient market entry for new therapeutics, ultimately benefiting patients.
The integration of AI into SSI Strategy’s consulting processes will help in navigating the complexities of bringing therapeutics to market, ensuring that products can reach their full therapeutic potential. This is particularly crucial in an industry where precision and compliance are paramount.
